06 Dec, EOD - Indian

SENSEX 81709.12 (-0.07)

Nifty 50 24677.8 (-0.12)

Nifty Bank 53509.5 (-0.18)

Nifty IT 44716.05 (-0.20)

Nifty Midcap 100 58704.6 (0.45)

Nifty Next 50 73040.4 (0.76)

Nifty Pharma 22434.75 (-0.13)

Nifty Smallcap 100 19492.1 (0.82)

06 Dec, EOD - Global

NIKKEI 225 39091.17 (-0.77)

HANG SENG 19865.85 (1.56)

S&P 6096.5 (-0.07)

Login/Signup

You are Here : Home > Research

16-May-2023

Pfizer

PAT up 3.07%

'For the quarter ending March 2023, standalone Net sales (including other operating income) of Pfizer has increased 4.18% to Rs 572.64 crore compared to quarter ended Mar 2022.Operating profit margin has jumped from 30.10% to 31.76%, leading to 9.92% rise in operating profit to Rs 181.87 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 13.03% to 12.22%.   Purchase of finished goods cost fell from 31.79% to 26.11%.   Employee cost decreased from 14.15% to 11.29%.   Other expenses rose from 15.67% to 18.93%.   

Other income up 83.29% to Rs 31.38 crore.  PBIDT rose 16.80% to Rs 213.25 crore.  Provision for interest fell 34.29% to Rs 2.53 crore.  Loan funds rose to Rs 41.15 crore as of 31 March 2023 from Rs 39.25 crore as of 31 March 2022.  Inventories declined from Rs 448.90 crore as of 31 March 2022 to Rs 417.70 crore as of 31 March 2023.&...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information

  • Results-Analysis   (29-Oct-2024)

    Pfizer

    PAT up 6.3%

  • Results-Analysis   (30-Jul-2024)

    Pfizer

    OP increased 60.32%

  • Results-Analysis   (28-Oct-2023)

    Pfizer

    PAT down 52.11%

  • Results-Analysis   (16-May-2023)

    Pfizer

    PAT up 3.07%